Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
---|
04/11/2013 | US20130090324 Novel prolylcarboxypeptidase inhibitors |
04/11/2013 | US20130090323 Heterocyclic compounds and their uses |
04/11/2013 | US20130090310 Compositions and methods for inhibition of the jak pathway |
04/11/2013 | US20130089625 Compounds Useful as Inhibitors of ATR Kinase |
04/11/2013 | US20130089624 Compounds Useful as Inhibitors of ATR Kinase |
04/11/2013 | US20130089613 Compounds Having Activating Effect on Subtypes of Peroxisome Proliferator-Activated Receptors and its Preparation Method and Uses |
04/11/2013 | US20130089518 Novel pyrimidine derivatives |
04/11/2013 | US20130087768 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode |
04/11/2013 | CA2851082A1 1,3-substituted azetidine pde10 inhibitors |
04/11/2013 | CA2851037A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases |
04/11/2013 | CA2850082A1 Ethynyl derivatives as mglur5 allosteric modulators |
04/11/2013 | CA2850013A1 Herbicidal pyridazinone derivatives |
04/10/2013 | EP2578569A1 Heterocyclic ring compound and h1 receptor antagonist |
04/10/2013 | EP2576543A1 Pyrazole compounds as sigma receptor inhibitors |
04/10/2013 | EP2576536A2 Haematopoietic-prostaglandin d2 synthase inhibitors |
04/10/2013 | EP2576520A1 Radiolabeled compounds and methods thereof |
04/10/2013 | EP2576510A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
04/10/2013 | EP2576507A1 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
04/10/2013 | EP2575866A1 Inhibitors of hcv ns5a |
04/10/2013 | EP2575465A1 Salts of raltegravir |
04/10/2013 | CN1759114B Heterocyclic N-aryl carboxamides as cytokine inhibitors |
04/10/2013 | CN103038218A Condensed ring pyridine compound |
04/10/2013 | CN103030635A Biaryl heterocycle-substituted oxazolidinone antibacterial drug |
04/10/2013 | CN103030634A Bicyclo-containing oxazolidinone antibiotics |
04/10/2013 | CN103030585A Heterocyclic compound, organic light-emitting diode and flat panel display device |
04/10/2013 | CN101903353B Aminopyrazole derivatives |
04/10/2013 | CN101801940B Substituted isoxazoline compound and pest control agent |
04/09/2013 | US8415486 IAP inhibitors |
04/09/2013 | US8415482 Proline derivatives |
04/09/2013 | US8415477 Violet laser excitable dyes and their method of use |
04/09/2013 | US8415469 Compounds and methods for kinase modulation, and indications therefor |
04/09/2013 | US8415382 Substituted benzazoles and methods of their use as inhibitors of RAF Kinase |
04/09/2013 | US8415379 Pyridines |
04/09/2013 | US8415378 Isoxazol-3(2H)-one analogs as therapeutic agents |
04/09/2013 | US8415359 Phenylpyrrole derivative |
04/09/2013 | US8415349 Dicycloazaalkane derivatives, preparation processes and medical uses thereof |
04/09/2013 | US8415348 Nitrogenated derivatives of pancratistatin |
04/09/2013 | US8415347 Substituted tetracyclic tetahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
04/09/2013 | US8415346 Inhibitors of Janus kinases |
04/09/2013 | US8415343 Autoimmune diseases; antiinflammatory agents; antiproliferative agents; benzodiazepine compound |
04/09/2013 | US8415340 Triazine kinase inhibitors |
04/09/2013 | US8415310 Isoxazoline derivatives as antiparasitic agents |
04/09/2013 | CA2531050C Pharmaceutical compounds |
04/04/2013 | WO2013049726A2 Processes for making compounds useful as inhibitors of atr kinase |
04/04/2013 | WO2013049722A1 Compounds useful as inhibitors of atr kinase |
04/04/2013 | WO2013049720A1 Compounds useful as inhibitors of atr kinase |
04/04/2013 | WO2013049719A1 Compounds useful as inhibitors of atr kinase |
04/04/2013 | WO2013049686A1 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders |
04/04/2013 | WO2013049559A1 Pyridine derivatives |
04/04/2013 | WO2013049250A1 Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer |
04/04/2013 | WO2013049119A1 Selective nr2b antagonists |
04/04/2013 | WO2013049104A1 Pyridinedione carboxamide inhibitors of endothelial lipase |
04/04/2013 | WO2013048949A2 Selective nr2b antagonists |
04/04/2013 | WO2013048942A1 Quinolinone carboxamide inhibitors of endothelial lipase |
04/04/2013 | WO2013048928A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors |
04/04/2013 | WO2013047813A1 1,2,4-triazine-6-carboxamide derivative |
04/04/2013 | WO2013047411A1 Novel triazine derivative and ultraviolet absorbent |
04/04/2013 | WO2013046136A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
04/04/2013 | WO2013045516A1 Viral replication inhibitors |
04/04/2013 | WO2013044865A1 Oxazolidinone antibiotics containing fused ring |
04/04/2013 | WO2013044845A1 Biaryl heterocycle substituted oxazolidinon antibacterial drug |
04/04/2013 | WO2013044816A1 Crystalline forms of azilsartan and preparation and uses thereof |
04/04/2013 | WO2012177844A3 Substituted imidazopyridinyl-aminopyridine compounds |
04/04/2013 | WO2012161622A3 Incretin hormone secretion stimulators, method for producing and using same |
04/04/2013 | WO2011070179A8 Process for the preparation of propionic acid derivatives |
04/04/2013 | US20130085275 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
04/04/2013 | US20130085150 Analogues for the treatment or prevention of flavivirus infections |
04/04/2013 | US20130085148 Pyridine Derivatives |
04/04/2013 | US20130085147 Hepatitis C Virus Inhibitors |
04/04/2013 | US20130085140 Indenoisoquinolinone derivatives, manufacturing method and medical use thereof |
04/04/2013 | US20130085138 Selective NR2B Antagonists |
04/04/2013 | US20130085132 Pyrazole compound and pharmaceutical use thereof |
04/04/2013 | US20130085131 Heterocyclic compounds and their uses |
04/04/2013 | US20130085126 Pyrazole compounds |
04/04/2013 | US20130084346 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
04/04/2013 | US20130081213 Cationic 6-aminoindolines, dyeing compositions containing them, processes and uses thereof |
04/04/2013 | CA2850566A1 Processes for making compounds useful as inhibitors of atr kinase |
04/04/2013 | CA2850564A1 Compounds useful as inhibitors of atr kinase |
04/04/2013 | CA2850551A1 Pyridine derivatives |
04/04/2013 | CA2850367A1 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders |
04/04/2013 | CA2850166A1 Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer |
04/04/2013 | CA2850003A1 Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses |
04/04/2013 | CA2849995A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
04/04/2013 | CA2848604A1 Viral replication inhibitors |
04/03/2013 | EP2574607A1 PDE10 modulators |
04/03/2013 | CN103025731A 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
04/03/2013 | CN103025730A Processes for preparing linezolid |
04/03/2013 | CN103025728A 2,3,5-trisubstituted thiophene compounds and uses thereof |
04/03/2013 | CN103025725A Hetero ring compound |
04/03/2013 | CN103025724A 哌啶衍生物 Piperidine derivatives |
04/03/2013 | CN103025721A Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and pharmaceutical composition comprising the same |
04/03/2013 | CN103025716A Bicyclic compound derivatives and their use as acc inhibitors |
04/03/2013 | CN103012390A Indole derivatives as S1P1 receptor |
04/03/2013 | CN103012389A Rivaroxaban intermediate preparation method |
04/03/2013 | CN103012388A Preparation methods for rivaroxaban and intermediate thereof, and intermediate compounds |
04/03/2013 | CN103012387A Method for preparing iloperidone |
04/03/2013 | CN103012378A 3-phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto |
04/03/2013 | CN103012376A Amide derivatives |
04/03/2013 | CN103012365A Preparation method of optical switch molecular compound based on diarylethene Schiff base |
04/03/2013 | CN103012314A Sulfonamide compound and preparation method as well as application thereof |